Medical insurance drugs can be purchased at designated medical institutions and designated retail pharmacies "dual channel"

　　Chinanews.com, Beijing, May 10th. The reporter learned from the National Medical Insurance Administration on the 10th that in order to ensure the smooth implementation of the drugs negotiated by the National Medical Insurance, improve the level of guaranteed supply, and better meet the reasonable drug needs of the insured patients, the National Medical Insurance Bureau recently met with The National Health Commission issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations."

　　"Dual channel" refers to the mechanism that meets reasonable needs for negotiating drug supply guarantees and clinical use through two channels, designated medical institutions and designated retail pharmacies, and simultaneously incorporates them into the medical insurance payment mechanism.

　　The "Guiding Opinions" is divided into seven parts, respectively, in terms of classified management, selection of pharmacies, standardized use, improvement of payment policies, optimization of handling management, strengthening of supervision, and strengthening of leadership, etc., it puts forward requirements for the "dual channel" management of negotiated drugs.

　　The purpose of issuing the "Guiding Opinions" is to give full play to the flexible and widely distributed services of designated retail pharmacies, include them in the scope of negotiated drug supply guarantees, increase drug supply channels and patient medication options, and promote designated retail pharmacies to improve service quality and negotiation Availability of medicines.

For the first time, the "Guiding Opinions" included designated retail pharmacies at the national level into the scope of the supply of medical insurance drugs, and implemented a unified payment policy with medical institutions.

　　The promulgation of the "Guiding Opinions" marks a step towards diversification in the supply of negotiated drugs. This will have an important impact on solving the "difficulty in entering the hospital" of negotiated drugs and promoting the reform of the drug management system in medical institutions.

(Finish)